Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

3M Health Care

3M Healthcare offers medical products, including wound care solutions and oral care solutions that help prevent infec... read more Featured Products: More products

Download Mobile App




Vascular Access Port Protector Reduces Contamination Risk

By HospiMedica International staff writers
Posted on 22 Mar 2017
A new cap for open female Luer connectors ensures that all intraluminal vascular access points can be protected through passive disinfection.

The 3M Curos Stopper--part of the 3M Curos disinfecting port protector family--is a single-use, bright red cap that contains a 70% isopropyl alcohol (IPA) reservoir to disinfect the port against several microorganisms commonly associated with central line-associated bloodstream infection (CLABSI), such as Staphylococcus aureus, Escherichia coli, and Candida albicans. More...
It is indicated for use on open female Luers, such as stopcocks and catheter hubs, providing timesaving, consistent, and reliable disinfection, while keeping ports protected from contamination when not in use.

Curos Stopper caps come in single form for home use and in ancillary areas where intravenous (IV) poles are not commonly used, and in strip form to facilitate staff compliance with port disinfection. Each cap can disinfect a port in just one minute, providing protection for up to seven days (if not removed). Curos Stoppers are designed to fit a wide range of stopcocks and hemodialysis catheter hubs and offer a way to hold pressure while providing fast, passive disinfection to critical areas. The 3M Curos disinfecting port protector family also includes passive disinfection solutions for needleless connectors, male Luers, and Tego hemodialysis connectors.

“3M is committed to helping clinicians reduce infections. We have the science to deliver evidence-based solutions that help protect patient safety, reduce the risks of costly complications, improve patient outcomes and, in turn, reduce care delivery costs,” said Pat Parks, MD, PhD, medical director in the 3M critical and chronic care solutions division. “Adding Curos Stopper caps to our innovative IV care portfolio brings us one step closer to helping clinicians protect every patient’s vascular catheter, from insertion to removal.”

CLABSI is defined as a primary bloodstream infection in a patient who had a central line in place within 48 hours before the development of the infection. Patients in the intensive care unit (ICU) and patients receiving hemodialysis are the most vulnerable, and it is estimated that 250,000 CLABSI occur annually, associated with mortality rates of 10-20%. Passive disinfection caps for needleless connectors have been shown to reduce the risk of CLABSI, and also eliminate the variability encountered by human scrubbing.


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Open Stapler
PROXIMATE Linear Cutter
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.